| 000 | 01795 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514010920.0 | ||
| 264 | 0 | _c20011101 | |
| 008 | 200111s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/s0014-2999(01)01263-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSantillán, R | |
| 245 | 0 | 0 |
_aAssessment of the oestrogenic activity of the contraceptive progestin levonorgestrel and its non-phenolic metabolites. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cSep 2001 |
||
| 300 |
_a167-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aContraceptive Agents, Female _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEstradiol _xanalogs & derivatives |
| 650 | 0 | 4 |
_aEstrogen Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aEstrogens _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFulvestrant |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLevonorgestrel _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPituitary Gland, Anterior _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Progesterone _xdrug effects |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xdrug effects |
| 650 | 0 | 4 |
_aSaccharomyces cerevisiae _xgenetics |
| 650 | 0 | 4 |
_abeta-Galactosidase _xdrug effects |
| 700 | 1 | _aPérez-Palacios, G | |
| 700 | 1 | _aReyes, M | |
| 700 | 1 | _aDamián-Matsumura, P | |
| 700 | 1 | _aGarcía, G A | |
| 700 | 1 | _aGrillasca, I | |
| 700 | 1 | _aLemus, A E | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 427 _gno. 2 _gp. 167-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0014-2999(01)01263-8 _zAvailable from publisher's website |
| 999 |
_c11479546 _d11479546 |
||